{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:53:39Z","timestamp":1761155619031},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Review of Pain"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1007\/s11916-000-0105-4","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T16:00:30Z","timestamp":1344441630000},"page":"287-294","source":"Crossref","is-referenced-by-count":13,"title":["Is fibromyalgia a distinct clinical syndrome?"],"prefix":"10.1007","volume":"4","author":[{"given":"Chi-lun","family":"Rau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Jon","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,1]]},"reference":[{"key":"105_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990, 33:160\u2013172.","journal-title":"Arthritis Rheum"},{"key":"105_CR2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00000441-199806000-00002","volume":"315","author":"GS Alarcon","year":"1998","unstructured":"Alarcon GS, Bradley LA, eds: Advances in fibromyalgia. Am J Med Sci 1998, 315:346\u2013404.","journal-title":"Am J Med Sci"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/art.1780400904","volume":"40","author":"F Wolfe","year":"1997","unstructured":"Wolfe F, Anderson J, Harkness D, et al.: A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997, 40:1560\u20131570. Examines the natural history of fibromyalgia in a large number of patients over more than 7 years and establishes the cost of this disorder to the United States economy as of the year 1994.","journal-title":"Arthritis Rheum"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00002508-199206000-00012","volume":"8","author":"C Henriksson","year":"1992","unstructured":"Henriksson C, Gundmark I, Bengtsson A, Ek AC: Living with fibromyalgia. Consequences for everyday life. Clin J Pain 1992, 8:138\u2013144.","journal-title":"Clin J Pain"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/09638289609166308","volume":"18","author":"C Henriksson","year":"1996","unstructured":"Henriksson C, Burckhardt C: Impact of fibromyalgia on everyday life: a study of women in the USA and Sweden. Disabil Rehabil 1996, 18:241\u2013248.","journal-title":"Disabil Rehabil"},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(86)90874-0","volume":"81","author":"IJ Russell","year":"1986","unstructured":"Russell IJ, Vipraio GA, Morgan WW, Bowden CL: Is there a metabolic basis for the fibrositis syndrome? Am J Med 1986, 81:50\u201356.","journal-title":"Am J Med"},{"key":"105_CR7","first-page":"944","volume":"22","author":"E Tunks","year":"1995","unstructured":"Tunks E, McCain GA, Hart LE, et al.: The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 1995, 22:944\u2013952.","journal-title":"J Rheumatol"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.1780260701","volume":"26","author":"SM Campbell","year":"1983","unstructured":"Campbell SM, Clark S, Tindall EA, et al.: Clinical characteristics of fibrositis. I. A \u201cblinded,\u201d controlled study of symptoms and tender points. Arthritis Rheum 1983, 26:817\u2013824.","journal-title":"Arthritis Rheum"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/art.1780310205","volume":"31","author":"RW Simms","year":"1988","unstructured":"Simms RW, Goldenberg DL, Felson DT, Mason JH: Tenderness in 75 anatomic sites. Distinguishing fibromyalgia patients from controls. Arthritis Rheum 1988, 31:182\u2013187.","journal-title":"Arthritis Rheum"},{"key":"105_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1300\/J094v06n01_09","volume":"6","author":"IJ Russell","year":"1998","unstructured":"Russell IJ: The reliability of algometry in the assessment of patients with fibromyalgia syndrome. J Musculoske Pain 1998, 6:139\u2013152.","journal-title":"J Musculoske Pain"},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.56.4.268","volume":"56","author":"F Wolfe","year":"1997","unstructured":"Wolfe F: The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic. Ann Rheum Dis 1997, 56:268\u2013271.","journal-title":"Ann Rheum Dis"},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","volume":"38","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Ross K, Anderson J, et al.: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995, 38:19\u201328.","journal-title":"Arthritis Rheum"},{"key":"105_CR13","first-page":"555","volume":"24","author":"F Wolfe","year":"1997","unstructured":"Wolfe F, Russell IJ, Vipraio GA, et al.: Serotonin levels, pain threshold, and FM. J Rheumatol 1997, 24:555\u2013559.","journal-title":"J Rheumatol"},{"key":"105_CR14","first-page":"151","volume":"22","author":"F Wolfe","year":"1995","unstructured":"Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995, 22:151\u2013156.","journal-title":"J Rheumatol"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/berh.1999.0034","volume":"13","author":"IJ Russell","year":"1999","unstructured":"Russell IJ: Is fibromyalgia a distinct clinical entity? The clinical investigator\u2019s evidence. Ballieres Clin Rheumatol 1999, 13:445\u2013454.","journal-title":"Ballieres Clin Rheumatol"},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bmj.308.6940.1323","volume":"308","author":"DR McCance","year":"1994","unstructured":"McCance DR, Hanson RL, Charles MA, et al.: Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994, 308:1323\u20131328.","journal-title":"BMJ"},{"key":"105_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00031305.1985.10479387","volume":"39","author":"M Paik","year":"1985","unstructured":"Paik M: A graphic representation of a three-way contingency table: Simpson\u2019s paradox and correlation. Am Statistician 1985, 39:53\u201354.","journal-title":"Am Statistician"},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.1780371105","volume":"37","author":"LJ Crofford","year":"1994","unstructured":"Crofford LJ, Pillemer SR, Kalogeras KT, et al.: Hypothalamicpituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994, 37:1583\u20131592.","journal-title":"Arthritis Rheum"},{"issue":"suppl_1","key":"105_CR19","first-page":"109","volume":"3","author":"RM Bennett","year":"1995","unstructured":"Bennett RM, Clark SR, Burckhardt CS, Cook D: IGF-1 assays and other GH tests in 500 fibromyalgia patients [abstract]. J Musculoske Pain 1995, 3(suppl_1):109.","journal-title":"J Musculoske Pain"},{"key":"105_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9343(97)00351-3","volume":"104","author":"RM Bennett","year":"1998","unstructured":"Bennett RM, Clark SC, Walczyk J: A randomized, doubleblind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 1998, 104:227\u2013231.","journal-title":"Am J Med"},{"key":"105_CR21","first-page":"239","volume":"15","author":"I Bou-Holaigah","year":"1997","unstructured":"Bou-Holaigah I, Calkins H, Flynn JA, et al.: Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997, 15:239\u2013246.","journal-title":"Clin Exp Rheumatol"},{"key":"105_CR22","first-page":"714","volume":"24","author":"M Martinez-Lavin","year":"1997","unstructured":"Martinez-Lavin M, Hermosillo AG, Mendoza C, et al.: Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 1997, 24:714\u2013718.","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"105_CR23","first-page":"78","volume":"3","author":"DJ Clauw","year":"1995","unstructured":"Clauw DJ, Radulovic D, Heshmat Y, Barbey JT: Heart rate variability as a measure of autonomic function in patients with fibromyalgia (FM) and chronic fatigue syndrome (CFS) [abstract]. J Musculoske Pain 1995, 3(suppl 1):78.","journal-title":"J Musculoske Pain"},{"key":"105_CR24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/1529-0131(199811)41:11<1966::AID-ART11>3.0.CO;2-O","volume":"41","author":"M Martinez-Lavin","year":"1998","unstructured":"Martinez-Lavin M, Hermosillo AG, Rosas M, Soto ME: Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 1998, 41:1966\u20131971. Shows that at least some patients with FMS exhibit a diurnal dysfunction in their autonomic nervous system control of heart rate regulation.","journal-title":"Arthritis Rheum"},{"key":"105_CR25","first-page":"18","volume-title":"The Management of Pain","author":"JJ Bonica","year":"1990","unstructured":"Bonica JJ: Definitions and taxonomy of pain. In The Management of Pain, vol 1, edn 2. Edited by Bonica JJ et al. Philadelphia: Lea & Febiger; 1990:18\u201327.","edition":"edn 2"},{"key":"105_CR26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.1381521","volume":"257","author":"AB Malmberg","year":"1992","unstructured":"Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992, 257:1276\u20131279.","journal-title":"Science"},{"key":"105_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1300\/J094v04n01_06","volume":"1","author":"IJ Russell","year":"1996","unstructured":"Russell IJ: Neurochemical pathogenesis of fibromyalgia syndrome. J Musculoske Pain 1996, 1:61\u201392.","journal-title":"J Musculoske Pain"},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1300\/J094v03n03_03","volume":"3","author":"U Hoheisel","year":"1995","unstructured":"Hoheisel U, Mense S, Ratkai M: Effects of spinal cord superfusion with substance P on the excitability of rat dorsal horn neurons processing input from deep tissues. J Musculoske Pain 1995, 3:23\u201343.","journal-title":"J Musculoske Pain"},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3959(88)90019-X","volume":"32","author":"H Vaeroy","year":"1988","unstructured":"Vaeroy H, Helle R, Forre O, et al.: Elevated CSF levels of substance P and high incidence of Raynaud\u2019s phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988, 32:21\u201326.","journal-title":"Pain"},{"key":"105_CR30","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell IJ, Orr MD, Littman B, et al.: Elevated cerebrospinal levels of substance P patients with fibromyalgia syndrome. Arthritis Rheum 1994, 37:1593\u20131601.","journal-title":"Arthritis Rheum"},{"issue":"suppl 1","key":"105_CR31","first-page":"4","volume":"3","author":"M Welin","year":"1995","unstructured":"Welin M, Bragee B, Nyberg F, Kristiansson M: Elevated substance P levels are contrasted by a decrease in metenkephalin-arg-Phe levels in CSF from fibromyalgia patients [abstract]. J Musculoske Pain 1995, 3(suppl 1):4.","journal-title":"J Musculoske Pain"},{"key":"105_CR32","first-page":"445","volume-title":"Regional cerebral blood flow (Rcbf) in the caudate nucleus and thalamus of fibromyalgia (FM) patients is associated with the cerebrospinal fluid (CSF) levels of substance P (SP) [abstract]","author":"KR Alberts","year":"1996","unstructured":"Alberts KR, Bradley LA, Mountz JM, et al.: Regional cerebral blood flow (Rcbf) in the caudate nucleus and thalamus of fibromyalgia (FM) patients is associated with the cerebrospinal fluid (CSF) levels of substance P (SP) [abstract]. In 8th World Congress on Pain, Aug 17\u201322. Seattle, WA: IASP Press; 1996:445."},{"issue":"suppl 2","key":"105_CR33","first-page":"77","volume":"6","author":"IJ Russell","year":"1998","unstructured":"Russell IJ, Fletcher EM, Vipraio GA, et al.: Cerebrospinal fluid [CSF] substance P [SP] in fibromyalgia: changes in CSF SP over time parallel changes in clinical activity [abstract]. J Musculoske Pain 1998, 6(suppl 2):77.","journal-title":"J Musculoske Pain"},{"key":"105_CR34","first-page":"1564","volume":"26","author":"SL Giovengo","year":"1999","unstructured":"Giovengo SL, Russell IJ, Larson AA: Increased concentrations of nerve growth factor (NGF) in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol 1999, 26:1564\u20131569.","journal-title":"J Rheumatol"},{"key":"105_CR35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0006-291X(84)80360-5","volume":"125","author":"F Nyberg","year":"1984","unstructured":"Nyberg F, LeGreves P, Sundqvist C, Terenius L: Characterization of substance P(1-7) and (1-8) generating enzyme in human cerebrospinal fluid. Biochem Biophys Res Commun 1984, 125:244\u2013250.","journal-title":"Biochem Biophys Res Commun"},{"key":"105_CR36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3940(94)90315-8","volume":"178","author":"RYU Yukhananov","year":"1994","unstructured":"Yukhananov RYU, Larson AA: An N-terminal fragment of substance P, Substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord. Neurosci Lett 1994, 178:163\u2013166.","journal-title":"Neurosci Lett"},{"key":"105_CR37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1523\/JNEUROSCI.10-04-01309.1990","volume":"10","author":"SR Skilling","year":"1990","unstructured":"Skilling SR, Smullin DH, Larson AA: Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception. J Neurosci 1990, 10:1309\u20131318.","journal-title":"J Neurosci"},{"issue":"suppl 1","key":"105_CR38","first-page":"5","volume":"3","author":"IJ Russell","year":"1995","unstructured":"Russell IJ, Orr MD, Michalek JE, et al.: Substance P (SP), SP endopeptidase activity, and SP N-terminal peptide fragment (SP1-7) in fibromyalgia syndrome cerebrospinal fluid [abstract]. J Musculoske Pain 1995, 3(suppl 1):5.","journal-title":"J Musculoske Pain"},{"key":"105_CR39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0304-3940(98)00937-9","volume":"259","author":"MJ Schwarz","year":"1999","unstructured":"Schwarz MJ, Spath M, M\u00fcller-Bardorff H, et al.: Relationship of substance P, 5-hydroxyindole acetic acid, and tryptophan in serum of fibromyalgia patients. Neurosci Lett 1999, 259:196\u2013198.","journal-title":"Neurosci Lett"},{"key":"105_CR40","first-page":"104","volume":"19","author":"IJ Russell","year":"1992","unstructured":"Russell IJ, Michalek JE, Vipraio GA, et al.: Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia\/fibrositis syndrome. J Rheumatol 1992, 19:104\u2013109.","journal-title":"J Rheumatol"},{"key":"105_CR41","first-page":"458","volume":"88","author":"T Stratz","year":"1993","unstructured":"Stratz T, Samborski W, Hrycaj P, et al.: Serotonin concentration in serum of patients with generalized tendomyopathy (fibromyalgia) and chronic polyarthritis [in German]. Med Klin 1993, 88:458\u2013462.","journal-title":"Med Klin"},{"key":"105_CR42","first-page":"1986","volume":"20","author":"P Hrycaj","year":"1993","unstructured":"Hrycaj P, Stratz T, Muller W: Platelet 3H-imipramine uptake receptor density and serum serotonin in patients with fibromyalgia\/fibrositis syndrome. J Rheumatol 1993, 20:1986\u20131987.","journal-title":"J Rheumatol"},{"key":"105_CR43","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell IJ, Vipraio GA: Serotonin (5HT) in serum and platelets (PLT) from fibromyalgia patients (FS) and normal controls (NC) [abstract]. Arthritis Rheum 1994, 37(suppl):S214.","journal-title":"Arthritis Rheum"},{"key":"105_CR44","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","volume":"35","author":"IJ Russell","year":"1992","unstructured":"Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992, 35:550\u2013556.","journal-title":"Arthritis Rheum"},{"key":"105_CR45","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1002\/art.1780360922","volume":"36","author":"IJ Russell","year":"1993","unstructured":"Russell IJ, Vipraio GA, Acworth I: Abnormalities in the central nervous system [CNS] metabolism of tryptophan [TRY] to 3-hydroxy kynurenine [OHKY] in fibromyalgia syndrome [FS] [abstract]. Arthritis Rheum 1993, 36:S222.","journal-title":"Arthritis Rheum"},{"key":"105_CR46","first-page":"14","volume":"1","author":"Y-K Kang","year":"1998","unstructured":"Kang Y-K, Russell IJ, Vipraio GA, Acworth IN: Low urinary 5-hydroxyindole acetic acid in fibromyalgia syndrome: evidence in support of a serotonin-deficiency pathogenesis. Myalgia 1998, 1:14\u201321.","journal-title":"Myalgia"}],"container-title":["Current Review of Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-000-0105-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-000-0105-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-000-0105-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T08:06:44Z","timestamp":1714291604000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-000-0105-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s11916-000-0105-4","relation":{},"ISSN":["1069-5850"],"issn-type":[{"value":"1069-5850","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}